Israeli app Belong becomes world’s largest Social Network for cancer patients
A cancer diagnosis can be overwhelming: Suddenly you’re faced with a mountain of options to consider tests and drugs and side effects that might not show themselves for months. “You might think you More...
Eight Clinical Signs Suggestive Of Impending Death In Cancer Patients
While the diagnosis of an impending death is always sad, it can be important for patients, families, and clinicians as they make decisions related to hospital discharge, hospice referral, More...
Gamida Cell Has Success With Its Nicord Blood Cancer Medication
Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that the first person has been successfully transplanted with cryopreserved More...
Israeli Arabs Also Citizens of ‘Startup Nation’
Israeli Arabs are also getting in on the successes of startup nation. Doctor Amal Ayoub is the founder and CEO of Metallo-Therapy which has developed technology that better monitors malignant tumors. Metallo-Therapy More...
Nigella Lawson Creates Cookbook For Cancer Patients
Nigella Lawson, a noted British journalist and gourmet chef, has created a cookbook for people battling cancer, as reported by the London Evening Standard. The author of several books, including “How More...
Study: Osteoporosis Treatment May Benefit Breast Cancer Patients
Treatment approaches to reduce the risk of bone complications (metastasis) associated with breast cancer may be one step closer to becoming a reality. According to a study led by a team at the Research Institute More...
Can-Fite BioPharma Liver Drug Gets US Patent
Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a patent in the US for its More...
Study: Aspirin May Slow Breast Cancer Recurrence
– New findings published today in the journal Cancer Research reveal that some postmenopausal overweight breast cancer patients who use common anti-inflammatory drugs like aspirin or ibuprofen have significantly More...
Tesaro Reports Positive Phase III Results For Opko Nausea Drug
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration More...